$48.30 -0.94 (-1.91%)
2/10/2012 4:00 PM

Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Featured Broker Partners


Advertisement